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Neurobiology of Disease
Human Auditory Cortex Neurochemistry Reflects the
Presence and Severity of Tinnitus
William Sedley,1* Jehill Parikh,2* Richard A.E. Edden,3,4 Valerie Tait,5 XAndrew Blamire,2* and Timothy D. Griffiths1*
1Institute of Neuroscience and 2Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle Upon Tyne, NE1 7RU, United Kingdom, 3Russell
H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, 4F.M. Kirby
Centre for Functional MRI, Kennedy Krieger Institute, Baltimore, Maryland 21205, and 5Department of Audiology, Freeman Hospital, Newcastle Upon
Tyne, NE7 7DN, United Kingdom
It is not knownwhy tinnitus occurs in some cases of hearingdamagebut not others. Abnormalities of excitation–inhibitionbalance could
influence whether tinnitus develops and its severity if it does. Animal models of hearing damage, which also produce tinnitus based on
behavioral evidence, have identified abnormalities of GABAergic inhibition, both cortically and subcortically. However, the precise
relationships ofGABA inhibitory changes to tinnitus itself, as opposed toother consequences of hearingdamage, remainuncertain.Here,
we usedmagnetic resonance spectroscopy to non-invasively quantify GABA in the left (LAC) and right (RAC) auditory cortices of a group
of 14 patients with lateralized tinnitus (eight left ear) and 14 controls matched for age, sex, and hearing. We also explored the potential
relationships with other brainmetabolites (i.e., choline,N-acetylaspartate, and creatine). The presence of tinnitus was associated with a
reduction in auditory cortex GABA concentration. Regardless of tinnitus laterality, post hoc testing indicated reductions that were
significant in RAC and nonsignificant in LAC. Tinnitus severity and hearing loss were correlated positively with RAC choline but not
GABA. We discuss the results in the context of current models of tinnitus and methodological constraints.
Key words: auditory cortex; choline; GABA; MR spectroscopy; tinnitus
Introduction
Persistent sensation of sound in one or both ears (tinnitus) com-
monly results from certain cases of peripheral auditory damage.
Although initiated in the periphery, the importance of central
mechanisms in tinnitus is highlighted by reduced spontaneous
and sound-driven cochlear nerve firing, instances of exacerba-
tion attributable to sectioning the cochlear nerve, and excessive
activity in the central auditory pathway (Noren˜a and Farley,
2013). Although neuronal firing rates are usually elevated in
noise trauma animal models, the time course and tonotopic dis-
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Significance Statement
Permanently affecting one in seven adults, tinnitus lacks bothwidely effective treatments and adequate understanding of its brain
mechanisms. Existing animal models represent tinnitus that may not be distinguishable from homeostatic responses to the
auditory insults used to induce it. Human studies can bewell controlled in this regard but are usually not (with few evenmatching
control subjects for hearing loss) and are limited in scope as a result of relying solely on non-invasive recording techniques. Here,
we exploit recent advances in non-invasive spectroscopic techniques to establish, in a human study tightly controlled for hearing
loss and hyperacusis, that tinnitus is associated with a significant reduction in auditory cortex GABA concentration, which has
implications for understanding and treatment of the condition.
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tribution of these may or may not match those of the tinnitus
behavior (Eggermont, 2013). However, increased synchrony be-
tween neurons has been observed, in certain studies, to begin
immediately after noise trauma (thus mirroring tinnitus onset;
Noren˜a and Eggermont, 2003) and in the tonotopic region of
noise trauma (Seki and Eggermont, 2003). Human tinnitus pa-
tients exhibit excessive neural synchrony, in the form of abnor-
mal spontaneous electromagnetic field/potential oscillations in
auditory cortex (Weisz et al., 2007; Adjamian et al., 2012; Tass et
al., 2012) and increased responses to sound at various levels of the
central auditory pathway (Lanting et al., 2008; Melcher et al.,
2009; Gu et al., 2010). Although the exact role of these different
types of activity in tinnitus pathogenesis is still debated (Sedley
and Cummingham, 2013; De Ridder et al., 2015), they appear
important and might plausibly be produced or enhanced by de-
ficient inhibition in the central auditory pathway. If identified,
reversing such inhibitory deficiency via pharmacological or other
interventions could prove effective in treating tinnitus.
GABA systems in tinnitus
The inhibitory neurotransmitter GABA is instrumental in main-
taining excitation–inhibition balances. From first principles, in-
sufficient GABAergic inhibition could underlie tinnitus, or
elevated inhibition could act to compensate for it. Changes could
take the form of altered gross concentration, relative distribution
in the tissue, receptor affinity, or receptor density. The only rel-
evant study measuring GABA directly compared measurements
from rats with behavioral evidence of chronic tinnitus, after noise
exposure, with those from unexposed controls (Brozoski et al.,
2012). Significant differences were found only at the level of the
auditory thalamus, contralateral to the exposed ear, with exposed
rats showing lower GABA concentrations. Studies using flavo-
protein autofluorescence to measure the spatial spread of neural
responses have found evidence of reducedGABAergic inhibition,
associated with noise trauma animal tinnitus models, in the dor-
sal cochlear nucleus (Middleton et al., 2011) and auditory cortex
(Llano et al., 2012). Chronic salicylate exposure (which causes
tinnitus) has been found to result in reduced expression of glu-
tamic acid decarboxylase (which converts glutamate to GABA)
and reduced GABA receptor affinity in the inferior colliculus of
rats (Bauer et al., 2000). Although indicative of GABAergic defi-
ciency, these studies do not uniquely attribute observed abnor-
malities to tinnitus specifically, as opposed to other consequences
of the auditory insults applied. Indirect evidence of the impor-
tance of GABA systems in tinnitus comes from a number of hu-
man and animal studies finding improvements in tinnitus
measures after administration of drugs that increase GABA con-
centration (Brozoski et al., 2007) or have a GABAergic action
(Han et al., 2012; Zheng et al., 2012). Furthermore, withdrawal
from chronic benzodiazepine use is a potent inducer of tinnitus
(Busto et al., 1986, 1988), suggesting a direct relationship be-
tween GABA systems and tinnitus.
Magnetic resonance spectroscopy in tinnitus patients
Magnetic resonance spectroscopy (MRS) is a non-invasive
method capable of making brain neurochemical measurements
in humans and has been proposed as a potentially useful tool for
studying tinnitus (Cacace and Silver, 2007).We are aware of only
one published report ofMRS in tinnitus (Kilicarslan et al., 2014),
which measuredN-acetylaspartate (NAA) and creatine in acous-
tic neuroma patients but without studying other metabolites or a
control group. Therefore, we applied the technique to the bilat-
eral auditory cortices of a group of chronic tinnitus patients and
age/hearing-matched controls to highlight abnormalities specif-
ically linked to tinnitus. Given the pre hoc focus on GABA, we
used methods optimized for GABA estimation.
Materials andMethods
Subjects. We studied a group of 14 patients (six females) with predomi-
nantly or entirely unilateral tinnitus (eight left, six right) and 14 controls
(seven females) matched for age and hearing loss. Lateralized tinnitus
was studied to assess hemispheric bias of any neurochemical changes in
terms of left versus right and ipsilateral versus contralateral. Exactly half
of each group had normal (20 dB hearing loss) mean hearing thresh-
olds in frequencies between 0.25 and 8 kHz so that the effects of hearing
loss on cortical neurochemistry could be studied. Exclusion criteria in-
cluded any neurological disorder other than tinnitus, the use of sedating
or GABA acting medications, and contraindications to MRI.
Assessment of tinnitus phenomenology. The diagnosis of tinnitus was
made based on a clinical history of persistent simple auditory percepts
heard all or most of the time, when not being masked by environmental
sounds, for a duration of 6 months. Controls were screened for the
presence of tinnitus and excluded if they experienced any persistent
sounds in either ear on a regular or permanent basis. Quantification of
tinnitus severity was performed in three ways: (1) completion of the
tinnitus handicap inventory (THI; Newman et al., 1996), which mea-
sures the effect of tinnitus rather than its loudness; (2) visual analog
scoring (VAS) of subjective tinnitus loudness; and (3) VAS assessment of
the distress caused by tinnitus. VAS measures were indicated on a con-
tinuous scale from 0 to 10, with 0 being no sound at all or no distress, and
10 being the loudest sound in existence or the most distress it is possible
to experience. In a novel approach to disentangling chronic from acute
influences on tinnitus (which might have different correlates), for each
VAS, subjects provided four responses: (1) an “average” measure, indi-
cating their response with respect to a typical or average day; (2) a “min-
imum” response, indicating their lowest score applicable over the past 3
months; (3) a “maximum” response, indicating their highest score appli-
cable over the past 3 months; and (4) a “now” measure, indicating their
response applicable at the time of the experiment. These measures were
converted to two values to be used for the analysis of MRS data: (1) an
“overall” score, which was simply the average response; and (2) a “cur-
rent” score, derived from interpolation, onto a scale of 0–10, of the now
score between the minimum and maximum responses, such that the
minimum response was 0, the average response was 5, and themaximum
response was 10. Hyperacusis was quantified in all subjects using the
hyperacusis questionnaire (HQ; Khalfa et al., 2002). Audiological assess-
ment for all subjects included pure tone audiometry (PTA) in 1 dB steps
at frequencies of 0.25, 0.5, 1, 2, 4, 6, and 8 kHz. PTA was performed in
ascending frequencies in the left and then the right ear, with three repe-
titions of each frequency in immediate succession, and the median value
across the three repetitions was taken.
MRS acquisition. GABA has three distinct peaks in its magnetic reso-
nance spectrum, but each of these coincides in frequencywith the peak of
a more abundant metabolite, necessitating the use of a specific GABA
measurement technique to quantify its concentration (Puts and Edden,
2012; Mullins et al., 2014). We used the Mescher-Garwood proton re-
solved spectroscopy (MEGA-PRESS) technique (Mescher et al., 1998), in
which alternate acquisitions are applied an editing pulse at 1.9 ppm,
which modulates all three of the GABA peaks attributable to J coupling.
Subtraction of the EDIT-OFF from EDIT-ON spectra thus allows sepa-
ration of the GABA signal at 3 ppm from the overlying creatine signal.
MEGA-PRESS spectra were acquired from each of the left (LAC) and
right (RAC) auditory cortex of each subject on a Phillips Achieva 3 Tesla
MRI scanner using an eight-channel head coil. Specific sequence param-
eters included the following: TR, 2000 ms; TE, 68 ms; 320 averages;
acquisition bandwidth, 1000 Hz; scan duration, 11 min; sinc Gaussian
editing pulse applied at 1.9 ppm (during EDIT-ON scans) and 7.5 ppm
(during EDIT-OFF scans); voxel size, 45 (anteroposterior) 32 (right to
left)  20 (foot to head) mm for both LAC and RAC; variable power
radiofrequency pulses with optimized relaxation delays (VAPOR) water
suppression (Tka´c et al., 1999). Non-water-suppressed spectra were also
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obtained from each auditory cortex (PRESS: TE, 68 ms; TR, 2000 ms; 10
averages). Previous T1w structural scans (3DMPRAGE; sagittal acquisi-
tion aligned with the anterior commissure–posterior commissure line; 1
mm isotropic resolution; matrix, 240 240  180; TR, 9.6 ms; TE, 4.6
ms; flip angle, 8°; sensitivity-encoded factor 2) were acquired to aid po-
sitioning of the MRS voxels in the LAC and RAC (for details, see Fig. 1).
Macromolecular suppression editingwas not performed tomaximize the
signal-to-noise ratio for GABA (i.e., GABA plus macromolecules)
quantification using the MEGA-PRESS acquisition (Edden et al., 2012).
To reduce sources of noise or bias, all subjects were requested to refrain
from alcohol for 24 h before the study and caffeine on the day of the
study, scans were performed at approximately the same time eachmorn-
ing, the scanner was not used after any high-demand sequences to pre-
vent scanner frequency drifts that might have influenced the MEGA-
PRESS acquisition (Harris et al., 2014), and LAC and RAC were scanned
in random order. Subjects all listened to music or radio during the ac-
quisition of the structural T1 image and voxel placement and had no
acoustic input besides scanner noise during MRS acquisition.
Spectroscopy data analysis. GABAquantificationwas performed using
the Gannet toolbox forMATLAB (Edden et al., 2014) and comprised the
following steps: (1) alignment of each pair (EDIT-ONandEDIT-OFF) of
spectra (Near et al., 2014); (2) subtraction of edited spectra, to yield
GABA spectra, and averaging across acquisitions; and (3) fitting a Gauss-
ian function to the GABA peak at 3 ppm and quantifying GABA based on
the area under the curve. For one typical edited spectrum and Gaussian
fit, see Figure 1, B and C, respectively. Water level was obtained from a
Gaussian–Lorentzian fit to the non-water-suppressed data. Tissue frac-
tions of graymatter (GM), whitematter (WM), and CSFwithin theMRS
voxels were calculated based on automated segmentation in SPM12
(http://www.fil.ion.ucl.ac.uk/spm/software/spm12/), using a volume
mask generated from the voxel position in Gannet (Harris et al., 2015).
The final measurement of interest, GABA concentration, was estimated
relative to water amplitude, accounting for metabolite relaxation times
and tissue fractions, as discussed by Gao et al. (2015). Choline, creatine,
andNAAamplitudeswere quantified fromnon-edited spectra only using
the AMARES (Advanced Method for Accurate, Robust, and Efficient
Spectral fitting ofMRS data with use of prior knowledge) algorithm from
jMRUI (Naressi et al., 2001), and similarly to GABA were converted to
tissue concentrations by taking account of water level, tissue fractions,
and known tissue metabolite relaxation times from the literature
(Mlyna´rik et al., 2001; Ethofer et al., 2003). As part of the quality assur-
ance routine, MRS fit quality was assessed by an experienced physicist;
the spectra were rejected if the Gannet fit error was10% (GABA mea-
surements) or metabolite line width was 12 Hz (NAA, creatine, and
choline).
Statistical analysis. Nonparametric statistics were used, namely the
Friedman’s test for main effects of group, withWilcoxon’s rank-sum test
for post hoc group differences in individual hemispheres, and Spearman’s
rank correlation coefficients for correlations with tinnitus-related or
other continuous variables. GABA was treated as the primary outcome
measure and therefore was not subject to multiple comparison correc-
tion. Choline, creatine, and NAA were treated as exploratory and there-
fore subject to Bonferroni’s correction. All statistical tests were two
tailed.
Results
Spectroscopy results overview
Gaussian fit errors of theGABA spectrawere all10%, except for
one subject in whom the LAC fit error was 15%. This spectrum
was reacquired, with an equal fit error in the second acquisition,
and the GABA values obtained from the two spectra were aver-
aged. All line widths for non-GABA metabolites were 12 Hz.
Table 1 shows all metabolite concentrations for tinnitus and con-
trol groups. It can be seen from this that all metabolites were less
abundant in LAC than RAC by 20%. The absence of any rela-
tive differences between metabolites suggests that this was an
issue of decreased signal from a particular voxel location, as has
been reported in phantom studies (Edden and Barker, 2007), as
opposed to chemical shift misregistration; in this phenomenon,
the spatial distance between the intended and sampled voxel lo-
cations varies for the different metabolites, thus producing vary-
ing degrees of signal loss (as opposed to the consistent 20%
reduction we observed).
GABA spectroscopy results
Compared with controls, the tinnitus group showed GABA de-
creases in the LAC (median, 0.99 vs 1.08 mM/L) and RAC (me-
dian 1.12 vs 1.28 mM/L). Friedman’s test showed a significant
main effect of subject group (p  0.015), and Wilcoxon’s rank-
sum tests found the difference to be significant in the RAC (p
0.018) but not LAC (p  0.30). The reduction in RAC GABA
concentration in the tinnitus group remained significant (p 
0.0308) after excluding a control outlier from the analysis. These
results are shown in Table 1 and Figure 2. There was no signifi-
cant difference in RACGABA concentration between the left and
right ear tinnitus patients (p  0.85). GABA concentrations
showed no significant correlation with age, sex, hearing loss,
hyperacusis, or any of the tinnitus severity measures.
Figure 1. Example GABA spectrum acquisition from the RAC in one typical subject. A, Or-
thogonal section view (neurological convention; L, left; R, right) of voxel placement. Voxels
were placed parallel with and superiorly abutting the Sylvian fissure and were otherwise cen-
tered on Heschl’s sulcus. This volume encompassed nearly all of Heschl’s gyrus, including the
primary auditory cortex, the planum temporale, the superior temporal sulcus, planum polare,
and also small parts of the insula andmiddle temporal gyrus adjacent to these auditory regions.
B, Edited spectrum, including theGABApeak for quantification at 3ppm.C, Expanded viewofB,
showing 3 ppm GABA peak and fitted Gaussian function used for quantification.
Table 1. Metabolite concentrations for tinnitus and control groups
LAC RAC
Control (mM/L),
n 14
Tinnitus (mM/L),
n 14 p
Control
(mM/L)
Tinnitus
(mM/L) p
Combined
p
GABA 1.08 (0.24) 0.99 (0.13) 0.30 1.28 (0.12) 1.12 (0.10) 0.018 0.015
Choline 2.72 (0.60) 2.60 (0.38) 3.43 (0.82) 3.23 (0.71) 0.15
NAA 13.5 (2.17) 13.7 (1.64) 15.2 (2.22) 15.3 (1.47) 0.67
Creatine 8.03 (2.36) 7.76 (1.48) 9.75 (2.13) 9.61 (4.22) 0.21
When applicable, values are median (interquartile range). Combined p values are uncorrected (although GABA
represents a primary hypothesis) and are based on Friedman’s test, treating hemisphere as a blocking variable.
Where these are significant, p values are shown for the LAC and RAC,which are based onWilcoxon’s rank-sum tests.
Significant group differences are shown in bold.
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Subject characteristics
Fourteen tinnitus patients and an equal number of matched
controls were studied. No significant differences were present
between groups in terms of age, hearing loss in either ear, or
hyperacusis. There was one extra female subject in the control
group comparedwith the tinnitus group.Mean tinnitus duration
was 9.4 years (range, 2–29 years). Eight of the tinnitus patients
had left-ear-predominant tinnitus compared with 6 right ear.
Table 2 summarizes the group characteristics and Figure 3A the
group hearing thresholds.
There were significant positive correlations between certain
tinnitus measures, as illustrated in Figure 3B. Most notably, THI
score correlated with hearing loss and hyperacusis, and VAS
overall tinnitus distress score correlated positively withHQ, THI,
and VAS overall tinnitus loudness scores. Based on these corre-
lations and our relative interest in certainmeasures above others,
we eliminated hyperacusis and overall VAS distress from addi-
tional analysis.
Structural brain changes
There were no (uncorrected) significant differences in GM,WM,
or CSF concentrations in the LAC or RAC between the tinnitus
and control groups. However, in the subject group as a whole,
GM fraction correlated negatively with both age (LAC,  
0.57, p 0.0016; RAC, 0.48, p 0.009) and hearing loss
(LAC, 0.59, p 0.001; RAC, 0.49, p 0.0078), and
CSF fraction correlated positively with age (LAC,   0.52, p 
0.0047; RAC,  0.56, p 0.0019) and hearing loss (LAC, 
0.25, p 0.20; RAC,  0.40, p 0.033).
Choline spectroscopy
Choline concentrationwas not significantly different between the
tinnitus and control groups (see Table 1). RAC choline correlated
with overall VAS tinnitus loudness ( 0.050, p 0.069 uncor-
rected), THI score ( 0.73, p 0.034 corrected), hearing loss in
the subject group as a whole (  0.62, p  0.0055 corrected),
hearing loss in the tinnitus group (  0.81, p  0.0078 cor-
rected), and hearing loss in the control group ( 0.41, p 0.14
uncorrected). These correlations are illustrated in Figure 4. Be-
cause choline is present in higher concentrations in WM than
GM (Rae, 2014) and tissue composition correlated with age and
hearing loss, we repeated significant correlation analyses after
partialing out age, hearing loss, and all tissue fractions from both
RAC choline concentration and the subject variable of interest. It
should be kept inmind that such extensive partialization removes
a lot of variance from the data, so the same strength of correlation
Figure 2. Auditory cortex GABA concentrations in the tinnitus and control groups. AC, Audi-
tory cortex. Boxes indicate interquartile range,with horizontal line at themedian, andwhiskers
indicate full range, barring outliers that are indicated with signs. GABA was significantly
reduced ( p0.05) as amain effect of subject group (tinnitus vs control) and in theRAC. Results
displayed here are also tabulated in Table 1.
Table 2. Subject characteristics of tinnitus and control groups
Control Tinnitus Difference ( p)
Group size (n) 14 14
Age (years) 55.7	 10.6 53.7	 15.1 0.87
Sex (n females) 7 of 14 6 of 14
Mean left-ear hearing loss (dB) 19.4	 14.4 18.8	 15.3 0.91
Mean right-ear hearing loss (dB) 17.4	 11.5 18.0	 20.2 0.58
Hyperacusis (HQ) 11.6	 5.7 13.6	 6.4 0.30
t duration (years) 9.4	 7.6
Laterality (n left) 8 of 14
THI 26.7	 13.2
Overall loudness 3.9	 1.8
Current loudness 4.3	 2.3
Overall distress 3.1	 1.6
Current distress 3.9	 (2.2
When applicable, values are indicate mean	 SD. p value is between the tinnitus and control groups based on
Wilcoxon’s rank-sum statistic.
Figure 3. Hearing and tinnitus-related subject characteristics. A, Mean pure tone hearing
thresholds of the tinnitus and control groups. Error bars represent SEM. B, Positive nonpara-
metric correlations between hearing and tinnitus measures within the tinnitus group. Signifi-
cant ( p 0.05 uncorrected) correlations are denoted by asterisks. No negative correlations
close to significance were observed, hence only positive correlations are shown. MHL, Mean
hearing loss (in decibels; across all frequencies shown in A). Dur, Tinnitus duration (years);
OvLoud, overall VAS loudness; CurLoud, current VAS loudness; OvDist, overall VAS tinnitus dis-
tress; CurDist, current VAS tinnitus distress.
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cannot be expected. Nonetheless, these partial analyses showed
that the correlation between hearing loss and choline in thewhole
subject group remained significant (  0.39, p  0.040 uncor-
rected), and the majority of the correlation between choline and
THI score remained ( 0.41, p 0.15 uncorrected).
NAA and creatine spectroscopy
There were no group-level differences between tinnitus and con-
trol groups for NAA or creatine, in either auditory cortex, even
before Bonferroni’s correction. Choline and NAA both reflect
neuronal density (Miller et al., 1996); therefore, we tested
whether there were similar correlations with hearing loss and
THI scores with NAA, as there were for choline, which might
indicate a structural basis to observed changes. NAA did not
correlate significantly with either mean hearing loss (p  0.95
uncorrected) or THI score (p 0.76 uncorrected).
Discussion
We studied a group of tinnitus patients and controls matched for
age, sex, hearing loss, and hyperacusis; thus, observed differences
can reasonably be inferred to relate to tinnitus as opposed to any
of these confounding factors. Because we did not perform mac-
romolecule suppression, for reasons of preserving the signal-to-
noise ratio and allowing greater robustness to subject motion, all
GABA results should be considered as indicating GABA (i.e.,
GABA plus macromolecules). This means that, as with a large
proportion of humanMRS studies of GABA, there is a theoretical
possibility that a proportion of the findings might relate to mol-
ecules other than GABA. MRS measurements were made from a
large voxel spanning almost all of auditory cortex, encompassing
primary and association areas, and including some areas of sur-
rounding non-auditory cortex. Although the primary reason for
using such a large sampling area was to provide a robust GABA
measurement, it is likely to have been appropriate in tinnitus, in
which ongoing abnormal neurophysiological signals have been
found to occur across a correspondingly large anatomical area as
opposed to just circumscribed parts of the auditory cortex (Sed-
ley et al., 2015). However, the exact size and position of the voxel
used could influence the sensitivity of our measurements to de-
tecting changes in other factors that might correlate with neu-
rotransmitter concentrations in more localized parts of the
auditory cortex. Such a voxel size and placement issue might
explain why we did not observe a relationship between GABA
concentration and hearing loss, as was reported recently in
association with age-related hearing loss (Gao et al., 2015). Spe-
cifically, voxels in the present study were placed to capture as
much of auditory cortex as possible and as little of non-auditory
areas, which meant that the primary auditory cortex was at the
superior edge of the voxel and slightly anterior of center. Con-
versely, Gao et al. centered voxels onHeschl’s gyrus and therefore
on or near the primary auditory cortex. Thus, it is possible that
their results were relatively more strongly influenced by the pri-
mary auditory cortex than those in the present study. However,
our study had other methodological differences to this one, in-
cluding studying undifferentiated hearing loss as opposed to spe-
cifically the age-related type, and it is not knownwhether hearing
loss of different etiologies also differs in its neurochemical corre-
lates. For all significant results, there were qualitatively similar
findings in the LAC as in the RAC, but the findings were much
stronger and only significant in the RAC. The 20% loss of signal
observed in the LAC can be potentially explained by spatial effects
influencing GABA MRS measurements (Edden and Barker,
2007). Thus, it is possible that in reality the observed neurochem-
ical correlates of tinnitus are bilateral. However, we stress the
importance of obtaining direct evidence rather than assuming
this to be the case. Although there was a slight excess of left-ear-
predominant tinnitus subjects (8 vs 6), there were no significant
differences between left and right ear tinnitus even aftermarkedly
relaxing statistical thresholds, making tinnitus laterality a very
unlikely explanation.
GABA in tinnitus
We have demonstrated, for the first time, an auditory cortex
GABA deficit in human tinnitus subjects. Given the tight match-
ing of the control group for age and hearing loss, this deficit can
be specifically attributed to tinnitus itself. Presently, the implica-
tions of this finding for understanding tinnitus pathophysiology
as a whole are uncertain, although in light of findings in animal
tinnitus models (Middleton et al., 2011; Llano et al., 2012), it is
likely that this GABA deficiency is responsible for excessive mag-
nitude and lateral spread of cortical responses to thalamic stim-
ulation. Therefore, GABA deficiency may underlie excessive
sound-evoked (Gu et al., 2010) and spontaneous (Adjamian et
al., 2012) activity that has been observed previously in tinnitus in
humans, even after matching for hearing loss and hyperacusis.
However, GABA systems may have a more complex role in
tinnitus; a recent study found evidence of increased GABA-
mediated tonic inhibition in the auditory thalami of rats with
noise-induced tinnitus (Sametsky et al., 2015). This excess inhi-
bition was in turn linked to abnormal burst firing of thalamic
neurons, which has been argued to trigger abnormal cortical ac-
tivity linked to tinnitus (Llina´s et al., 1999). Thus, the net effect of
GABA on tinnitus-linked cortical activity may vary according to
such factors as anatomical location and receptor type. With re-
gard to the present results, it is possible that GABA deficiency is a
primary cause of tinnitus that, in conjunction with hearing loss,
removes the necessary inhibition to prevent spontaneous activity
in the auditory system from being perceived as tinnitus. In addi-
tion to a role in enhancing cortical responses to sounds or spon-
taneous subcortical activity, GABA deficiency in the auditory
cortex might also act in other ways. Various brain structures
outside the auditory system, including limbic, parietal, and pre-
frontal regions, have been implicated in tinnitus (Lockwood et
al., 1998; Moazami-Goudarzi et al., 2010; Vanneste et al., 2010;
De Ridder et al., 2013); together, these may mediate the entry of
the tinnitus percept into conscious perception and mediate its
cognitive and affective consequences. The nonprimary auditory
cortex shows rich connectivity with many of these regions in
Figure 4. Correlations between choline concentration and subject variables.A, Relationship
betweenmeanhearing loss and RAC choline concentration in control (gray) and tinnitus (black)
groups. Individual dots denote individual subjects, and lines represent least squares best linear
fits. B, Spearman’s rank correlation coefficients () between choline and subjective tinnitus
variables in bilateral auditory cortices. OvLoud, VAS overall tinnitus loudness; CurLoud, VAS
current tinnitus loudness; CurDist, VAS current tinnitus distress. **p 0.01 uncorrected.
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association with tinnitus (De Ridder et al., 2013; Sedley et al.,
2015), and, although there is not yet direct evidence on the sub-
ject, it seems possible that GABA changes in the nonprimary
auditory cortexmight affect entry of the tinnitus signal intowider
cortical networks. Because the present data cannot separate
GABA changes in the primary from the nonprimary auditory
cortex, this possibility should be considered. It is also plausible
that GABA deficiency is the direct consequence of chronic stim-
ulation (by tinnitus or its precursors originating subcortically) of
the auditory cortex, but we are not aware of any evidence about
the effect of chronic sensory stimulation on cortical GABA con-
centration that could address this possibility. It is also uncertain
whether the GABA deficit is a cause or consequence of tinnitus.
Although there was not a relationship between tinnitus duration
and GABA concentration, which would have favored the GABA
deficit being a consequence of tinnitus, this question remains
open. Regardless of the exact origin and role of cortical GABA in
tinnitus, it seems probable that it is a significant positive force in
its pathogenesis, because reduced GABA concentration most
likely indicates reduced GABAergic inhibition and therefore a
relative excess of excitation in the auditory system. There remains
the need for additional understanding of other aspects of GABA
systems in tinnitus, such as receptor density, which presently only
has limited evidence in humans (Shulman et al., 2000). As well as
replicating the present findings, future studies of GABA systems
in humansmight involve combining GABAmeasurements using
MRS with GABA receptor density measurements using positron
emission tomography. In animals, a number of additional
measures, such as glutamic acid decarboxylase expression and
GABAA receptor subunit composition, might also be measu-
red simultaneously. Studies might also examine both acute and
chronic tinnitus to establish the temporal order of tinnitus phe-
nomenology and GABA changes and also the effect of chronic
physiological auditory stimulation on GABA systems.
Choline in tinnitus
Our results indicate that auditory cortex choline concentration
correlates positively with both tinnitus severity (in terms of dis-
tress and possibly loudness) and hearing loss (particularly in the
tinnitus group). Choline is strongly influenced by neuronal den-
sity (Miller et al., 1996), and GM loss (hence increased WM/GM
ratio) increasedwith hearing loss, as reported previously (Husain
et al., 2011). However, given the persistence of observed findings
after statistically adjusting for the influence of GMandWH tissue
fractions, it seems probable that choline relates directly to hearing
loss and tinnitus. Because choline measured by MRS reflects in-
creased neuronal membrane turnover (Rae, 2014), which may
relate to plasticity (Gutie´rrez-Ferna´ndez et al., 2012), and (al-
though acetylcholine barely contributes to the choline signal)
correlates strongly with local concentration of acetylcholine
(Wang et al., 2008), we cannot presently determinewhich of these
factors is perturbed as a function of hearing loss and tinnitus
severity. Additional work to directly measure neuronal plasticity
and acetylcholine is required to understand the relationship be-
tween choline and tinnitus.
In summary, we have specifically related the presence and
severity of tinnitus, after eliminating confounding factors, to
non-invasively measured metabolite concentrations in the audi-
tory cortex. The finding of a GABA deficit in tinnitus patients is
beyond a homeostatic response to hearing loss, underscores the
importance of GABA systems in the pathophysiology of tinnitus,
and may help to direct future treatments.
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